These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18728269)

  • 1. Opportunities for enhancing the FDA guidance on pharmacovigilance.
    Psaty BM; Vandenbroucke JP
    JAMA; 2008 Aug; 300(8):952-4. PubMed ID: 18728269
    [No Abstract]   [Full Text] [Related]  

  • 2. Company sponsored clinical research--it can be trusted.
    Arnold J; Hofmann L; Rupinskas VR
    Decubitus; 1989 Feb; 2(1):22-4. PubMed ID: 2751831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynavax trial halted.
    DeFrancesco L
    Nat Biotechnol; 2008 May; 26(5):484. PubMed ID: 18464766
    [No Abstract]   [Full Text] [Related]  

  • 4. New FDA guidance documents.
    Bradshaw ST
    Food Drug Law J; 2007; 62(2):429-31. PubMed ID: 17632971
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA: biotech friend or foe?
    Lamont A
    Biotechnology (N Y); 1991 Mar; 9(3):248, 250. PubMed ID: 1367299
    [No Abstract]   [Full Text] [Related]  

  • 6. ORA's role at FDA headquarters and in the field for product recalls.
    Whetstone SN
    Food Drug Law J; 1998; 53(3):513-6. PubMed ID: 10346723
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharma's year of trouble and strife.
    Frantz S
    Nat Rev Drug Discov; 2006 Jan; 5(1):7-9. PubMed ID: 16485339
    [No Abstract]   [Full Text] [Related]  

  • 8. Helpful web sites for food safety and older adults.
    Ocampo C
    J Nutr Elder; 2009 Apr; 28(2):200-1. PubMed ID: 21184366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FDA and product recalls.
    Meadows M
    FDA Consum; 2006; 40(3):30-5. PubMed ID: 16906665
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA gets advice on Modernization Act compliance.
    Marwick C
    JAMA; 1998 Oct; 280(14):1214-5. PubMed ID: 9786361
    [No Abstract]   [Full Text] [Related]  

  • 11. Guidance for industry on Population Pharmacokinetics; availability. Food and Drug Administration, HHS. Notice.
    Fed Regist; 1999 Feb; 64(27):6663-4. PubMed ID: 10557596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA guidance on antimicrobials aims to prevent resistance.
    O'Rourke K
    J Am Vet Med Assoc; 2003 Dec; 223(12):1714-5, 1719. PubMed ID: 14690196
    [No Abstract]   [Full Text] [Related]  

  • 13. Prescription for trouble: common drugs, hidden dangers. Tens of people are at risk.
    Consum Rep; 2006 Jan; 71(1):34-9. PubMed ID: 16491527
    [No Abstract]   [Full Text] [Related]  

  • 14. Product labeling: the FDA perspective.
    Barlow DA
    J Enterostomal Ther; 1986; 13(5):178-9. PubMed ID: 3639092
    [No Abstract]   [Full Text] [Related]  

  • 15. Study examines FDA warning letters about medical devices from 2009.
    Yang H; Hyman WA
    Biomed Instrum Technol; 2010; 44(4):336-8. PubMed ID: 20715963
    [No Abstract]   [Full Text] [Related]  

  • 16. Consumer-directed advertising of contraceptive drugs: the FDA, Depo-Provera, and product liability.
    Green W
    Food Drug Law J; 1995; 50(4):553-67. PubMed ID: 10343019
    [No Abstract]   [Full Text] [Related]  

  • 17. Informed consent and living human cells.
    Maloney DM
    Hum Res Rep; 2002 Jul; 17(7):3. PubMed ID: 12731490
    [No Abstract]   [Full Text] [Related]  

  • 18. Reporting to the FDA.
    Dippel JV
    RN; 1993 Dec; 56(12):61-2. PubMed ID: 8265993
    [No Abstract]   [Full Text] [Related]  

  • 19. Forensic pharmacovigilance and substandard or counterfeit drugs.
    Labadie J
    Int J Risk Saf Med; 2012; 24(1):37-9. PubMed ID: 22436258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving women's health through modernization of our bioinformatics infrastructure.
    Oliva A; Pinnow E; Levin R; Uhl K
    Clin Pharmacol Ther; 2008 Jan; 83(1):192-5. PubMed ID: 17987048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.